Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin/Tizanidine vs. Pregabalin in Fibromyalgia (PROBE)
NCT07382921Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tizanidine in fibromyalgia (FM) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Average pain intensity at 12 weeks. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
tizanidine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07382921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07382921.